510(k) K261569
K261569 is an FDA 510(k) premarket notification submitted by Lifesignals, Inc. for the device "UbiqVue 2AYe Cardiac System (UX2253)". The FDA issued a decision of Substantially Equivalent on July 9, 2026. The device falls under product code DRG (Transmitters And Receivers, Physiological Signal, Radiofrequency), a Class II device regulated under 21 CFR 870.2910. Lifesignals, Inc. has at least 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 9, 2026
- Date Received
- May 12, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Transmitters And Receivers, Physiological Signal, Radiofrequency
- Device Class
- Class II
- Regulation Number
- 870.2910
- Review Panel
- CV
- Submission Type